Menu

Non-Governmental

Democratic Senator’s Illness Stalls Action on Drug Pricing Indefinitely

Tom Mirga and Ron Shinkman, Editor at Large 340B Report Views
Sen. Ben Ray Lujan's (D-N.M.) recent stroke and absence makes it even less likely that Congress will pass Democratic drug pricing legislation any time soon.

Prospects for passage of Democratic drug pricing legislation as part of the Build Back Better (BBB) Act dimmed again last week with news that Sen. Ben Ray Lujan (D-N.M.) had a stroke on Jan 27.

Lujan’s chief of

…
Read More »

ICER Says Four Drugs Are Cost-Effective in Keeping COVID-19 Patients Out of Hospitals

Ron Shinkman 340B Report Views
The Institute for Clinical and Economic Review has tentatively concluded that four drugs have demonstrated effectiveness and value in reducing hospitalizations of COVID-19 patients.

The Institute for Clinical and Economic Review (ICER) has issued a draft report concluding four drugs have demonstrated effectiveness and value in reducing hospitalizations of COVID-19 patients. The independent nonprofit group evaluates prescription drugs and medical treatments’ cost

…
Read More »

Scholarship Created in Memory of Long-Time 340B Leader Carl Taylor

Ron Shinkman 340B Report Views
The Carl Taylor Pharmacy Administration Scholarship at the University of North Carolina (UNC) Eshelman School of Pharmacy was announced this morning at the 340B Coalition Winter Conference in San Diego. Taylor, 76, the longtime pharmacy director at Piedmont Health Services in Chapel Hill, N.C., died last Sept. 24.

An endowed scholarship at the University of North Carolina (UNC) Eshelman School of Pharmacy has been established in memory of Carl Taylor, the longtime pharmacy director at Piedmont Health Services in Chapel Hill, N.C. Taylor, age 76, died last

…
Read More »

In His First Public Comments, Ex-HHS Top Lawyer Stands by 340B Contract Pharmacy Advisory Opinion

Tom Mirga, Editor at Large 340B Report Views
Ex-HHS General Counsel Robert Charrow during a webinar yesterday defended his since-withdrawn 340B contract pharmacy advisory opinion.

Former U.S. Health and Human Services Department General Counsel Robert Charrow yesterday defended his strongly worded and colorful December 2020 advisory opinion, since vacated by a court and withdrawn by HHS, that the 340B statute unambiguously requires drug manufacturers

…
Read More »

Health Centers Launch a New National Advocacy Group

Tom Mirga, Editor at Large 340B Report Views
Kerry Hydash (left) is Board Chair and Amanda Pears Kelly is Executive Director of the new health center group Advocates for Community Health.

Community health center leaders have created a new membership organization—Advocates for Community Health (ACH)—to influence federal health care policy and “drive a new vision for the role health centers can and should play in an evolving 21st century health

…
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Site Footer Live